These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1752960)

  • 41. Isolation and characterization of a tumor necrosis factor binding protein from urine.
    Olsson I; Lantz M; Nilsson E; Peetre C; Thysell H; Grubb A; Adolf G
    Eur J Haematol; 1989 Mar; 42(3):270-5. PubMed ID: 2924890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice.
    Gascon MP; Porchet HC; Le Cotonnec JY; Ythier A; Wallach D; Piguet PF; Grau GE
    Drug Metab Dispos; 1992; 20(4):592-5. PubMed ID: 1356740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNF inhibitor with a low molecular weight found in the human sera.
    Shimoda A; Hanaumi K; Kumagai K
    Tohoku J Exp Med; 1995 Dec; 177(4):327-35. PubMed ID: 8928192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of novel therapeutic agents for the treatment of serious infection.
    Dunn DL
    Am J Surg; 1993 Nov; 166(5):449-55. PubMed ID: 8238741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization.
    Li M; Xue Y; Chi L; Jin L
    Curr Protein Pept Sci; 2024; 25(6):480-491. PubMed ID: 38284716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.
    Kang I; Chang MY; Wight TN; Frevert CW
    J Histochem Cytochem; 2018 Apr; 66(4):241-259. PubMed ID: 29328866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
    Chiodelli P; Bugatti A; Urbinati C; Rusnati M
    Molecules; 2015 Apr; 20(4):6342-88. PubMed ID: 25867824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure.
    Byun S; Sinskey YL; Lu YC; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 2013 Dec; 540(1-2):1-8. PubMed ID: 24135706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana.
    Agbenorku P; Fugar S; Akpaloo J; Hoyte-Williams PE; Alhassan Z; Agyei F
    Int J Burns Trauma; 2013; 3(1):30-6. PubMed ID: 23386983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study.
    Kritikos O; Tsagarakis M; Tsoutsos D; Kittas C; Gorgoulis V; Papalois A; Giannopoulos A; Kakiopoulos G; Papadopoulos O
    Ann Burns Fire Disasters; 2012 Jun; 25(2):66-73. PubMed ID: 23233823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.
    Hofstra JJ; Vlaar AP; Prins DJ; Koh G; Levi M; Schultz MJ; Binnekade JM; Juffermans NP
    BMC Pulm Med; 2012 Aug; 12():43. PubMed ID: 22894723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular functions of syndecan-1 in disease.
    Teng YH; Aquino RS; Park PW
    Matrix Biol; 2012 Jan; 31(1):3-16. PubMed ID: 22033227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin reduced mortality and sepsis in severely burned children.
    Zayas GJ; Bonilla AM; Saliba MJ
    Ann Burns Fire Disasters; 2007 Mar; 20(1):29-34. PubMed ID: 21991064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock.
    Hayashida K; Chen Y; Bartlett AH; Park PW
    J Biol Chem; 2008 Jul; 283(29):19895-903. PubMed ID: 18499671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of interleukin-6 are not dependent on the kidney function.
    Nässberger L
    Mediators Inflamm; 1992; 1(3):197-9. PubMed ID: 18475461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.
    Bode L; Salvestrini C; Park PW; Li JP; Esko JD; Yamaguchi Y; Murch S; Freeze HH
    J Clin Invest; 2008 Jan; 118(1):229-38. PubMed ID: 18064305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retraction. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.
    J Clin Invest; 1993 Feb; 91(2):737. PubMed ID: 16695966
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.
    Ji SL; Cui HF; Shi F; Chi YQ; Cao JC; Geng MY; Guan HS
    World J Gastroenterol; 2004 Dec; 10(23):3490-4. PubMed ID: 15526371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats.
    Dobosz M; Mionskowska L; Hac S; Dobrowolski S; Dymecki D; Wajda Z
    World J Gastroenterol; 2004 Sep; 10(17):2553-6. PubMed ID: 15300904
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.